Analyst Research

Report Title Price
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Meda AB to Acquire Acton Pharmaceuticals Inc


Friday, 30 Aug 2013 06:00am EDT 

Meda AB announced that it has an agreement to acquire a United States company Acton Pharmaceuticals Inc, including the patent-protected product Aerospan. The purchase price amounts to USD 135 million. In addition there are a milestone payment of USD 10 million, and royalty milestones. The acquisition is expected to close during the fourth quarter of 2013, subject to customary closing conditions and the United States competition authorities giving their approval. Existing credit facilities will fund the acquisition. 

Company Quote

110.6
-0.9 -0.81%
11:29am EST